AP Insights, News, Videos, and More

Researchers at Temple University have been awarded a grant by the National Institute on Drug Abuse to study the mechanisms underlying the effect of COVID-19 on the blood-brain barrier and potential interactions between the virus and cocaine.

Individuals under the age of 40—particularly males—face higher risks from alcohol consumption than older adults and receive no health benefits from consuming alcohol, according to new research published this month in The Lancet.

Findings by researchers from Ohio State University Wexner Medical Center and College of Medicine, and the University of Michigan Medical School suggest central sensitization may be a key underlying factor complicating the treatment of chronic...

CODAC Behavioral Healthcare, a not-for-profit provider of outpatient opioid treatment in Rhode Island, announced on Monday that it has launched a mobile medical unit to dispense methadone, buprenorphine, and naltrexone for opioid use disorder...

An increased risk of personal histories of trauma combined with a greater vulnerability to alcohol-related deficits in the brain appear to work together to lead to more severe alcohol use disorders in women compared with men.

The national, not-for-profit organization’s new service will provide users with information on non-opioid pain alternatives and ways to reduce risks associated with prescribed opioids.

Buprenorphine prescriptions for young adults paid for by commercial insurance or cash, but not Medicaid, significantly decreased in the early months of the COVID-19 pandemic, according to a recent study.

The findings indicate underprescribing of such medications, despite their demonstrated effectiveness in reducing heavy drinking and/or relapse.